GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
AGARWAL, PANKAJ,YANG, LUN
申请号:
CA2845756
公开号:
CA2845756A1
申请日:
2012.08.17
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
Methods are provided for selecting a new therapeutic indication for at least one first pharmaceutical comprising the steps of: generating a drug-side effect (SE) association for said at least one first pharmaceutical generating a disease-side effect (SE) association for at least one disease or disorder and at least one second pharmaceutical intended for treatment of said at least one disease or disorder determining an association strength between the drug-side effect (SE) association and the disease- side effect (SE) association selecting said at least one disease or disorder as a new therapeutic indication for said at least one first pharmaceutical if said at least one first pharmaceutical induces at least one side effect which is the same as at least one side effect induced by at least one second pharmaceutical intended for treatment of said at least one disease or disorder.